Tuberculosis
894
65
90
602
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Published Results
127 trials with published results (14%)
Research Maturity
602 completed trials (67% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.5%
31 terminated out of 894 trials
95.1%
+8.6% vs benchmark
14%
122 trials in Phase 3/4
21%
127 of 602 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 602 completed trials
Clinical Trials (894)
ThiPhiSA: New Pathways to Prevention From Community TB Screening in South Africa
A Step Forward for Unraveling the Immune Mechanisms and Tools for Tuberculosis Spectrum Management
Training Protocol on the Natural History of Tuberculosis
Shortened Regimen for Drug-susceptible TB in Children
Targeted Universal TB Testing With Simultaneous TPT Prescribing Among People Living With HIV in South Africa
Candidate Clinical Correlate of Prognostic Outcome for TB Study
Single-Dose Study to Evaluate the PKs of Pretomanid in Participants With Renal Impairment Compared to Participants With Normal Renal Function
A Phase I Study Investigating the Local Tolerability and Pharmacokinetics of Isoniazid (INH) Inhalation by Wet Nebulization in Patients With Tuberculosis
A Novel Therapy With a 1-Month Ultrashort Regimen to Halt Progression From Latent Infection to Active Tuberculosis Among Close Contacts (The TB-YOUTH Study)
Evaluating the Pharmacokinetics, Safety, and Tolerability of Bedaquiline in Infants, Children, and Adolescents With Multidrug-Resistant Tuberculosis, Living With or Without HIV
Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST Study
Testing Health Workers At Risk to Advance Our Understanding of TB Infection
TBTC Study 26 PK: Rifapentine Pharmacokinetics in Children During Treatment of Latent TB Infection
Shaping a Community-based Pathway to Improve TB Surveillance Among African and Hindustan Immigrants Experiencing Vulnerabilities
Study of the Safety and Efficacy of the Subunit Recombinant Tuberculosis Vaccine GamTBvac
Detection of Mycobacterium Tuberculosis in Blood of TB Patients and Their Contacts in Uganda
An Evaluation of Traditional Directly Observed Therapy (DOT) and Electronic DOT for TB Treatment
Tuberculosis Clinical Registry in Europe
PREVAIL VIIIa: Evaluation of Latent Tuberculosis Infection Screening Methods in People Living With Retroviral Infection in Liberia
Rifapentine-Based Shorter Regimens for Tuberculosis and TB Infection in Kazakhstan